To assess removal of CMV by leucocyte depletion (LD) filters, we developed a spiking model of latent virus, using peripheral blood mononuclear cells (PBMC) infected by coculture with CMV-infected human fibroblasts. Infected PBMC were purified by dual magnetic column selection, then spiked into whole blood units or buffy coat pools prior to LD by filtration. CMV load and fibroblast contamination were assessed using quantitative CMV DNA real-time PCR and quantitative RT-PCR of mRNA encoding the fibroblastspecific splice variant of prolyl-4-hydroxylase, respectively. After correcting for fibroblastassociated CMV, the mean CMV load was reduced in whole blood by LD from 7.42 x 10 2 to 1.13 copies/µl (2.81 10 log reduction), and from 3.8 x 10 2 to 4.77 copies/µl (1.9 10 log reduction) inplatelets. These results suggest that LD by filtration reduces viral burden but does not completely remove CMV from blood components.
INTRODUCTION
Primary cytomegalovirus (CMV) infection results in life-long carriage of latent virus, notably in CD14+ monocytes 1 . Re-activation of donor CMV following transfusion 2 is avoided by selecting CMV-seronegative donors for vulnerable patients. Since universal leucocyte depletion (LD) has been widely implemented, it is debated whether LD alone could provide equivalent protection 3, 4 . Eight studies have shown no transmissions following pre-storage LD 5, 6 , but a recent study reports increased transmission from LD CMV seropositive components 7 Quantitative real-time PCR has the dynamic range to assess CMV removal by LD 8, 9 , but due to low copy number, we and others 9 have failed to detect viremia in sero-positive donorsand even optimal CMV PCR would require virtually all leucocytes in an LD component (< 10 6 ) 10 . We found techniques reported to increase CMV copy number (pollen 11 , interferon, hydrocortisone, GM-CSF and allogeneic cells 2 ) to be insufficiently robust for assessment of LD. We have previously used infected T-lymphocytes and realtime PCR to assess HTLV-I removal by LD
12
.
A CMV-infected T-cell line has also been described to measure CMV removal 13 , but T-cells are not a major physiological reservoir of CMV. We have therefore modified a previously described system 14 
MATERIALS AND METHODS
With Ethics Committee approval and donor consent, 450 ml blood donations from 6 CMV seronegative donors were collected into citrate phosphate dextrose. PBMC were prepared from a 24 ml aliquot by density gradient separation (mean yield 1.52 +/-0.27 x 10 For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From
RESULTS AND DISCUSSION
The mononuclear cell distribution in a single representative spiking sample was CD3+ 63%, CD14+ 11%, CD19+ 26%. Purification achieved mean fibroblast removal from whole blood and buffy coat-derived PBMC of 96.3 +/-5.4% and 77.21 +/-20.2% respectively, with corresponding CMV recoveries of 2.67 +/-1.87% and 13.9 +/-10.9%. The CMV signal attributable to fibroblasts in the whole blood spike was <1% in 5 samples, and 16% in the sixth, the corresponding figures for the platelet spike being <11% in 5 samples, and 37.7% in the sixth (Table 1 ).
All LD units contained <5 x 10 6 leucocytes/unit. After correcting for CMV attributable to fibroblasts, whole blood LD reduced the CMV load from a mean of 742 to a mean of 1.13
CMV genome copies/µl, a mean reduction of 2.81 +/-0.31 10 log ( Table 2) This system permits assessment of CMV removal by filtration using fresh PBMC, including the relevant CD14+ population. The 2.8 log reduction in CMV with whole blood LD is consistent with previous findings using either CMV-infected T cells 13 , or CMV antigenemic blood with 10-100 times lower CMV load than used here 16 . It was not possible to correlate CMV removal with residual leucocyte counts, since these were below the detection limit in all units. Although there were 2 samples in which the CMV contribution from fibroblasts was unusually high, this had no impact on the efficacy of the LD process. The incomplete CMV removal in our study cannot be attributed to filter We and others have previously reported >4 10 log monocyte reduction by whole blood LD 17, 18 . The cause of the discrepancy between monocyte and CMV removal is not clear, but with HTLV-infected T cells and similar filters, overall T cell reduction was also 1log greater than HTLV Tax removal 12 . It may be that monocytes activated by CMV infection are removed less well by filters than non-infected cells. Evidence for possible monocyte activation comes from recent observations reporting cytokine production by PBMC's exposed to CMV for only 18 hours, a CD14-dependent phenomenon 19 . The less efficient removal of CMV by platelet than by whole blood filtration was also found with HTLV 
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For ------------ Table 1 . CMV recovery in the mononuclear cell preparation used to spike whole blood units (n = 6) and platelet units (n=6). The proportion of CMV signal attributable to fibroblast contamination is also shown. A mean of 3 CMV copies/fibroblast is used in the calculation. --------- Table 2 . Contaminating fibroblasts and CMV copies in whole blood and pooled platelet units before and after LD (n = 6). The number of CMV copies is corrected for fibroblast contamination at 3 CMV copies/fibroblast.
